Status:
COMPLETED
Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Eligibility:
All Genders
18-65 years
Brief Summary
The purpose of this study is to determine the role of HIV-specific CD4 T cell responses and immune responses dependent upon these CD4 responses that develop when antiretroviral drugs are started durin...
Detailed Description
In some HIV patients with acute or early infection, effective long-term immunological control of HIV occurs, indicating that before HIV caused irreparable damage, their immune systems were able to mou...
Eligibility Criteria
Inclusion
- Acute or early HIV infection
- ART naive
- Willing to use acceptable forms of contraception
Exclusion
- Allergy/sensitivity to any components of the vaccine
- Currently involuntarily incarcerated
- Pregnant or breastfeeding
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00238459
Start Date
July 1 2005
End Date
October 1 2013
Last Update
November 20 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016
2
McGill University and University of Montreal
Montreal, Quebec, Canada